Fujitsu Japan has commenced a new research project to detect and analyse potential Covid-19 drugs by leveraging a fast supercomputer, Fugaku, co-developed by the company and RIKEN.
Fujitsu Japan Limited today announced that it will initiate a new research project with a research team led by Takefumi Yamashita, Project Associate Professor of Research Center for Advanced Science and Technology (RCAST)
GE Healthcare signed on to a new Australian research collaboration to develop artificial intelligence tools to quickly and automatically diagnose brain aneurysms.
Fujitsu brings healthcare to another level with its world-first hands-free speech translation device, leaving healthcare workers' hands free for care tasks.